GD2-Targeting CAR T Cells Show Promise in H3K27M-Mutated Gliomas

Skip Nav Destination

Article navigation

Research Watch| April 01 2022

Online Issn: 2159-8290

Print Issn: 2159-8274

2022

American Association for Cancer Research.

Cancer Discov (2022) 12 (4): 882.

Abstract

Three out of four patients treated with GD2-targeting CAR T cells showed radiographic and clinical improvement.

2022

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.